Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUCID DIAGNOSTICS INC.

1.29
+0.08006.61%
Post-market: 1.320.0300+2.33%19:47 EDT
Volume:1.37M
Turnover:1.72M
Market Cap:139.57M
PE:-1.03
High:1.30
Open:1.22
Low:1.21
Close:1.21
Loading ...

Lucid Diagnostics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
06 Jun

Corrected-Lucid Diagnostics: Files for Offering of 37 Mln Shares of Common Stock by Selling Stockholders - SEC Filing (Corrects Figure, Adds Dropped Words)

THOMSON REUTERS
·
04 Jun

BRIEF-Lucid Diagnostics Files For Offering Of 36 Million Shares Of Common Stock

Reuters
·
04 Jun

Lucid Diagnostics Inc: Files for Offering of 36 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
04 Jun

Lucid Diagnostics Inc - Enters Sales Agreement With Maxim Group - SEC Filing

THOMSON REUTERS
·
31 May

Lucid Diagnostics Inc. Announces $25 Million At-the-Market Share Offering Through Maxim Group LLC

Reuters
·
31 May

Lucid Diagnostics : May Offer, Sell Shares of Common Stock of up to $25 Mln

THOMSON REUTERS
·
31 May

Lucid Diagnostics to join Russell 2000, Russell 3000 indexes

TIPRANKS
·
27 May

Lucid Diagnostics director buys $457.6K in common stock

TIPRANKS
·
24 May

Director Dennis Matheis Acquires Common Shares of Lucid Diagnostics Inc

Reuters
·
23 May

Lucid Diagnostics Files Shelf Registration for Secondary Sale of 37 Million Shares by Convertible Note Holders

MT Newswires Live
·
22 May

BRIEF-Lucid Diagnostics Files Prospectus For Potential Offer, Sale From Time To Time Of Up To 37 Million Shares Of Common Stock By Selling Stockholders

Reuters
·
22 May

Lucid Diagnostics Files Prospectus for Potential Offer, Sale From Time to Time of up to 37 Mln Shares of Common Stock by Selling Stockholders

THOMSON REUTERS
·
22 May

Lucid Diagnostics Price Target Maintained With a $3.00/Share by Needham

Dow Jones
·
15 May

Lucid Diagnostics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Corrected-Lucid Diagnostics Inc: Qtrly Adj Loss per Share $0.16 (Not Gaap Loss)

THOMSON REUTERS
·
14 May

Lucid Diagnostics Q1 Adj. EPS $(0.16), Inline, Sales $800.00K Miss $1.28M Estimate

Benzinga
·
14 May

Lucid Diagnostics Inc: Qtrly Loss per Share $0.16

THOMSON REUTERS
·
14 May

Press Release: Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

Dow Jones
·
14 May

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

PR Newswire
·
01 May